These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3539980)

  • 21. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization.
    Dunaif A; Hoffman AR; Scully RE; Flier JS; Longcope C; Levy LJ; Crowley WF
    Obstet Gynecol; 1985 Oct; 66(4):545-52. PubMed ID: 3900841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.
    Barbieri RL
    J Reprod Med; 1994 May; 39(5):327-36. PubMed ID: 8064699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
    Dunaif A; Segal KR; Futterweit W; Dobrjansky A
    Diabetes; 1989 Sep; 38(9):1165-74. PubMed ID: 2670645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Amenorrhea, insulin resistance and acanthosis nigricans. A hyperandrogenic and a normoandrogenic clinical forms].
    Devoto E; Aravena L; Pacheco D; Fluxá F
    Rev Med Chil; 1993 Feb; 121(2):170-5. PubMed ID: 8303114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acromegaly with polycystic ovaries, hyperandrogenism, hirsutism, insulin resistance and acanthosis nigricans: a case report.
    Unal A; Sahin Y; Keleştimur F
    Endocr J; 1993 Apr; 40(2):207-11. PubMed ID: 7951506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect.
    Barbieri RL; Hornstein MD
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):685-703. PubMed ID: 3058472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Woman 19-old with hirsutism, obesity and acanthosis nigricans].
    Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K
    Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
    Esposito V; Federico P; Lo Iudice G; Rispoli C; Sabatino P; D'Alessandro B
    Minerva Endocrinol; 1992; 17(1):21-9. PubMed ID: 1495451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with acanthosis nigricans in obese adolescents.
    Galhardo J; Hunt LP; Shield JP
    Diabet Med; 2012 Jul; 29(7):e117-20. PubMed ID: 22288782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
    Legro RS; Finegood D; Dunaif A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease.
    Lanzone A; Fulghesu AM; Fortini A; Cutillo G; Cucinelli F; Di Simone N; Caruso A; Mancuso S
    Hum Reprod; 1991 Sep; 6(8):1043-9. PubMed ID: 1666896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.
    Kahn CR; Flier JS; Bar RS; Archer JA; Gorden P; Martin MM; Roth J
    N Engl J Med; 1976 Apr; 294(14):739-45. PubMed ID: 176581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism.
    Barbieri RL; Smith S; Ryan KJ
    Fertil Steril; 1988 Aug; 50(2):197-212. PubMed ID: 3294042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women.
    Grasinger CC; Wild RA; Parker IJ
    Fertil Steril; 1993 Mar; 59(3):583-6. PubMed ID: 8458461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.
    Barbieri RL
    Am J Obstet Gynecol; 2000 Dec; 183(6):1412-8. PubMed ID: 11120504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance.
    Moller DE; Cohen O; Yamaguchi Y; Assiz R; Grigorescu F; Eberle A; Morrow LA; Moses AC; Flier JS
    Diabetes; 1994 Feb; 43(2):247-55. PubMed ID: 8288049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Engin-Ustün Y; Ustün Y; Meydanli MM; Kafkasli A; Yetkin G
    Gynecol Endocrinol; 2006 Jun; 22(6):324-8. PubMed ID: 16785157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.